Co-expression of human complement regulatory proteins DAF and MCP with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects

[1]  B. Weill,et al.  Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. , 2004, Transplantation.

[2]  K. Matsunami,et al.  Effect of hybrid complement regulatory proteins on xenogeneic cells. , 2003, Biochemical and biophysical research communications.

[3]  T. Mollnes,et al.  Role of complement in xenotransplantation , 2002, Allergy.

[4]  Y. Muto,et al.  Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  P. Hobart,et al.  The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma. , 2002, Vaccine.

[6]  W. Li,et al.  Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. , 2001, FEMS immunology and medical microbiology.

[7]  J. Platt,et al.  The immunological barrier to xenotransplantation. , 2001, Immunity.

[8]  S. Russell,et al.  Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron , 2000, Gene Therapy.

[9]  C. Mold,et al.  Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack1 , 2000, The Journal of Immunology.

[10]  C. Mold,et al.  Structure/function studies of human decay‐accelerating factor , 2000, Immunology.

[11]  A. B. Stewart,et al.  Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. , 2000, Transplantation.

[12]  J. Balzarini,et al.  Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer , 2000, Cancer Gene Therapy.

[13]  E. Martínez-Salas.  Internal ribosome entry site biology and its use in expression vectors. , 1999, Current opinion in biotechnology.

[14]  J. Logan,et al.  Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates , 1999, Xenotransplantation.

[15]  M. Dunckley,et al.  Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors , 1998, Gene Therapy.

[16]  G. Palù,et al.  Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer , 1998, Gene Therapy.

[17]  S. Makrides.  Therapeutic inhibition of the complement system. , 1998, Pharmacological reviews.

[18]  P. Higgins,et al.  A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. , 1997, Journal of immunology.

[19]  J. Platt,et al.  Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. , 1997, Transplantation.

[20]  H. Ariga,et al.  Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. , 1994, Journal of immunology.

[21]  J. Sanes,et al.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos , 1991, Molecular and cellular biology.

[22]  J. Atkinson,et al.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b , 1986, The Journal of experimental medicine.

[23]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[24]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[25]  D. Fearon,et al.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. , 1982, Journal of immunology.

[26]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[27]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.